Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member B5 pseudogene 1 (DNAJB5P1) is a processed pseudogene related to the DNAJB5 gene, a member of the DnaJ/Hsp40 family of molecular chaperones[1][5]. Pseudogenes are segments of DNA that resemble protein-coding genes but generally lack the ability to encode functional proteins due to disruptive mutations or the absence of regulatory elements[2][6][7]. While some pseudogenes can be transcribed into non-coding RNAs with potential regulatory roles—such as acting as competitive endogenous RNAs (ceRNAs) or microRNA decoys—the specific functions of DNAJB5P1 are not established in the scientific literature[3][7]. Pseudogenes are not considered therapeutic targets (receptors, enzymes, etc.), and there are no approved drugs targeting DNAJB5P1. The presence and differential expression of pseudogenes may sometimes be leveraged as disease biomarkers, but this is not reported for DNAJB5P1[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member B5 pseudogene 1 (DNAJB5P1).